Pharmalicensing.com: PR Newswire http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us Pharmalicensing.com: PR Newswire http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 Moleac Announces Series A Investment SINGAPORE, April 3 /PRNewswire/ -- Singapore-based Moleac announced that it has raised US$3.5 million. This Series A investment comes from a group of private investors, who are based in both Europe... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/724 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/724 Thu, 03 Apr 2008 07:33:00 +0000 Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement GENEVA, June 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a Development and Licensing Agreement with Bionomics (ASX: BNO) was signed, under... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237 Wed, 18 Jun 2008 13:00:00 +0000 Non-Invasive Glucose Monitoring - Solianis Monitoring AG: Supported by the Zürich Cantonal Bank and the European Union ZURICH, Switzerland, May 5 /PRNewswire/ -- The research for non-invasive glucose monitoring has found new investors: The Zürich Cantonal Bank will invest in Solianis; together with a research grant... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/916 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/916 Mon, 05 May 2008 10:13:00 +0000 Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores NEW DELHI, August 21 /PRNewswire/ -- Omaxe Infrastructure & Construction Private Ltd(OICPL), a wholly owned subsidiary of Omaxe Ltd has received a Letter of Intent for the construction of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1554 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1554 Thu, 21 Aug 2008 15:50:00 +0000 Patheon Reaches Agreement With BSP Pharmaceuticals for Development and Manufacture of Cytotoxics TORONTO, July 2 /PRNewswire/ -- Patheon (TSX:PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, has completed a shareholders... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1336 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1336 Wed, 02 Jul 2008 22:00:00 +0000